TNFRSF8 and mature T-cell and NK-cell non-Hodgkin lymphoma: Brentuximab vedotin is an antibody drug conjugate consisting of an anti‐CD30 monoclonal antibody and a microtubule inhibitor, monomethyl auristatin E.3Our study is one of the first ones to report outcomes of Bv‐ICE in R/R PTCL.